These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19473225)

  • 1. Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel.
    Loven D; Levavi H; Sabach G; Zart R; Andras M; Fishman A; Karmon Y; Levi T; Dabby R; Gadoth N
    Eur J Cancer Care (Engl); 2009 Jan; 18(1):78-83. PubMed ID: 19473225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.
    Argyriou AA; Chroni E; Koutras A; Iconomou G; Papapetropoulos S; Polychronopoulos P; Kalofonos HP
    J Pain Symptom Manage; 2006 Sep; 32(3):237-44. PubMed ID: 16939848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.
    Argyriou AA; Chroni E; Koutras A; Ellul J; Papapetropoulos S; Katsoulas G; Iconomou G; Kalofonos HP
    Neurology; 2005 Jan; 64(1):26-31. PubMed ID: 15642899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
    Vahdat L; Papadopoulos K; Lange D; Leuin S; Kaufman E; Donovan D; Frederick D; Bagiella E; Tiersten A; Nichols G; Garrett T; Savage D; Antman K; Hesdorffer CS; Balmaceda C
    Clin Cancer Res; 2001 May; 7(5):1192-7. PubMed ID: 11350883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias.
    Jacobson SD; Loprinzi CL; Sloan JA; Wilke JL; Novotny PJ; Okuno SH; Jatoi A; Moynihan TJ
    J Support Oncol; 2003; 1(4):274-8. PubMed ID: 15334869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes.
    Mielke S; Sparreboom A; Mross K
    Eur J Cancer; 2006 Jan; 42(1):24-30. PubMed ID: 16293411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracing the incidence of paclitaxel-induced peripheral neuropathy.
    Argyriou AA
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):522-3. PubMed ID: 19674075
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.
    Pecorelli S; Favalli G; Gadducci A; Katsaros D; Panici PB; Carpi A; Scambia G; Ballardini M; Nanni O; Conte P;
    J Clin Oncol; 2009 Oct; 27(28):4642-8. PubMed ID: 19704064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery.
    Storey DJ; Colvin LA; Mackean MJ; Mitchell R; Fleetwood-Walker SM; Fallon MT
    J Pain Symptom Manage; 2010 Jun; 39(6):e2-4. PubMed ID: 20538177
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Choi BS; Robins HI
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):345-6. PubMed ID: 18026678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer.
    Mielke S; Sparreboom A; Steinberg SM; Gelderblom H; Unger C; Behringer D; Mross K
    Clin Cancer Res; 2005 Jul; 11(13):4843-50. PubMed ID: 16000582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer.
    van der Hoop RG; Vecht CJ; van der Burg ME; Elderson A; Boogerd W; Heimans JJ; Vries EP; van Houwelingen JC; Jennekens FG; Gispen WH
    N Engl J Med; 1990 Jan; 322(2):89-94. PubMed ID: 2152972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate ameliorates experimental vincristine neuropathy.
    Boyle FM; Wheeler HR; Shenfield GM
    J Pharmacol Exp Ther; 1996 Oct; 279(1):410-5. PubMed ID: 8859020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of duloxetine for Paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients.
    Otake A; Yoshino K; Ueda Y; Sawada K; Mabuchi S; Kimura T; Kobayashi E; Isobe A; Egawa-Takata T; Matsuzaki S; Fujita M; Kimura T
    Anticancer Res; 2015 Jan; 35(1):359-63. PubMed ID: 25550572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar enlargement, nuclear eccentricity and altered cell body immunostaining characteristics of large-sized sensory neurons following treatment of rats with paclitaxel.
    Jamieson SM; Liu JJ; Connor B; Dragunow M; McKeage MJ
    Neurotoxicology; 2007 Nov; 28(6):1092-8. PubMed ID: 17686523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside GM1 (porcine) ameliorates paclitaxel-induced neuropathy in rats.
    Chentanez V; Thanomsridejchai N; Duangmardphon N; Agthong S; Kaewsema A; Huanmanop T; Maneesri S
    J Med Assoc Thai; 2009 Jan; 92(1):50-7. PubMed ID: 19260244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.
    Ghoreishi Z; Esfahani A; Djazayeri A; Djalali M; Golestan B; Ayromlou H; Hashemzade S; Asghari Jafarabadi M; Montazeri V; Keshavarz SA; Darabi M
    BMC Cancer; 2012 Aug; 12():355. PubMed ID: 22894640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study.
    Stubblefield MD; Vahdat LT; Balmaceda CM; Troxel AB; Hesdorffer CS; Gooch CL
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):271-6. PubMed ID: 15997923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.